Related Experiment Video
Updated: May 19, 2026
08:46
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
In vitro potency tests: challenges encountered during method development
C L Yomayuza1, H-J Thiel, M König
1Institute of Virology, Faculty of Veterinary Medicine, Justus-Liebig, Universität, Giessen, Germany.
Developments in Biologicals
|August 15, 2012
Summary
Developing in vitro methods to assess rabies vaccine potency aims to replace the animal-based National Institutes of Health (NIH) test. This approach will ensure vaccine quality while reducing animal use in potency testing.
Area of Science:
- Veterinary immunology and vaccinology
- In vitro assay development
- Viral disease control
Background:
- Vaccines are crucial for controlling viral diseases in humans and animals.
- Current rabies vaccine potency testing relies on the National Institutes of Health (NIH) test, which uses thousands of mice annually.
- Rabies vaccine efficacy is linked to neutralizing antibodies against the viral glycoprotein (G), making G-protein content and structural integrity key potency indicators.
Purpose of the Study:
- To develop in vitro methods for determining rabies vaccine potency.
- To establish an assay panel for measuring antigenic content and quality.
- To enable precise prediction of rabies vaccine potency without animal testing.
Main Methods:
- Focus on developing and validating in vitro assays.
- Quantification of rabies virus glycoprotein (G) antigen.
- Assessment of antigen structural integrity and its impact on immunogenicity.
Main Results:
- Ongoing project focused on developing a panel of in vitro assays.
- Anticipated ability to measure antigenic content and antigen quality parameters.
- Development of a method to predict vaccine potency without animal use.
Conclusions:
- Development of in vitro assays offers a promising alternative to animal testing for rabies vaccines.
- Accurate potency assessment through in vitro methods can ensure vaccine quality and consistency.
- This research aims to significantly reduce or eliminate the need for animal experiments in rabies vaccine batch release.
Related Concept Videos
01:10In Vitro Drug Release Testing: Overview, Development and Validation
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
01:17In Vitro Drug Dissolution: Alternative Methods
Alternative drug dissolution methods include the rotating bottle, intrinsic dissolution test, peristalsis, and the Franz diffusion cell method. The rotating bottle method involves meticulously rotating tightly capped controlled-release beads in a temperature-controlled bath. Periodic decanting of samples allows for residue assay, followed by refilling with fresh medium and testing at various pH levels to emulate the gastrointestinal tract conditions.In contrast, the intrinsic dissolution test...
01:13In Vitro Drug Dissolution: Compendial Testing Models I
Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...
01:09In Vitro Drug Dissolution: Compendial Testing Models II
Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients, maintaining...
01:16In vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...